...small cap group, Muijrers' picks include cardiovascular and oncology company BioInvent International AB (SSE:BINV) and Laboratorios Farmaceuticos Rovi S.A....
...Francisco, Calif. Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Idenix Pharmaceuticals Inc. (NASDAQ:IDIX), Cambridge, Mass. Laboratorios Farmaceuticos Rovi S.A....

...related to the production of egg- and cell culture-derived vaccines. Further terms were not disclosed. Laboratorios Farmaceuticos Rovi S.A....

...the company terminated an agreement to license its recombinant virus-like particle (VLP) vaccine technology to Laboratorios Farmaceuticos Rovi S.A....

...and removed EU vaccine sales revenues from his model after Novavax ended negotiations to grant Laboratorios Farmaceuticos Rovi S.A....

...continue to seek partners for its vaccine technology in Europe (see BioCentury, July 6, 2009). Laboratorios Farmaceuticos Rovi S.A....

...Inc. (NASDAQ:NVAX) terminated an agreement to license its recombinant virus-like particle (VLP) vaccine technology to Laboratorios Farmaceuticos Rovi S.A....

...are finalized and are expected to include milestones and royalties. Novavax Inc. (NASDAQ:NVAX), Rockville, Md. Laboratorios Farmaceuticos Rovi S.A....

...after announcing an initial agreement to license its recombinant virus-like particle (VLP) vaccine technology to Laboratorios Farmaceuticos ROVI S.A....

...after announcing an initial agreement to license its recombinant virus-like particle (VLP) vaccine technology to Laboratorios Farmaceuticos ROVI S.A....